Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: The role of insurance mandates

Samantha F. Butts, Sarah Ratcliffe, Anuja Dokras, David Seifer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To explore correlates of diminished ovarian reserve (DOR) and predictors of assisted reproductive technologies (ART) treatment outcome in DOR cycles using the Society for Assisted Reproductive Technologies-Clinical Outcomes Reporting System (SART-CORS) database; we hypothesized that mandated state insurance coverage for ART is associated with the prevalence of DOR diagnosis in ART cycles and with treatment outcomes in DOR cycles. Design: Cross-sectional study using ART cycles between 2004 and 2007. Setting: Not applicable. Patient(s): A total of 182,779 fresh, nondonor, initial ART cycles in women up to age 40 years. Intervention(s): None. Main Outcome Measure(s): Prevalence of DOR and elevated FSH, odds ratio of DOR and elevated FSH in ART mandated vs. nonmandated states, live birth rates. Result(s): Compared with cycles performed in states with mandated ART coverage, cycles in states with no ART mandate were more likely to have DOR (adjusted odds ratio 1.43, 95% confidence interval 1.37-1.5) or elevated FSH (adjusted odds ratio 1.69, 95% confidence interval 1.56-1.85) as the sole reason for treatment. Lack of mandated ART coverage was associated with increased live birth rates in cycles diagnosed as DOR, but not in cycles characterized only by an elevated FSH. Conclusion(s): A significant association was observed between lack of mandated insurance for ART and the proportion of cycles treating DOR or elevated FSH. The presence or absence of state-mandated ART coverage could impact access to care and the mix of patients that pursue and initiate ART cycles in ways that influence these proportions. Additional studies are needed that consider the coalescence of insurance mandates, patient and provider factors, and state-level variables on the odds of specific infertility diagnoses and treatment prognosis.

Original languageEnglish (US)
JournalFertility and Sterility
Volume99
Issue number2
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Assisted Reproductive Techniques
Insurance
Therapeutics
Birth Rate
Odds Ratio
Live Birth
Menstrual Cycle
Ovarian Reserve
Confidence Intervals
Insurance Coverage
Infertility
Patient Care

Keywords

  • assisted reproductive technologies (ART)
  • Diminished ovarian reserve
  • elevated FSH
  • infertility insurance mandates
  • SART-CORS database

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years : The role of insurance mandates. / Butts, Samantha F.; Ratcliffe, Sarah; Dokras, Anuja; Seifer, David.

In: Fertility and Sterility, Vol. 99, No. 2, 02.2013.

Research output: Contribution to journalArticle

@article{cd3276d3caec4ea4a7c93f5f5e13b927,
title = "Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: The role of insurance mandates",
abstract = "Objective: To explore correlates of diminished ovarian reserve (DOR) and predictors of assisted reproductive technologies (ART) treatment outcome in DOR cycles using the Society for Assisted Reproductive Technologies-Clinical Outcomes Reporting System (SART-CORS) database; we hypothesized that mandated state insurance coverage for ART is associated with the prevalence of DOR diagnosis in ART cycles and with treatment outcomes in DOR cycles. Design: Cross-sectional study using ART cycles between 2004 and 2007. Setting: Not applicable. Patient(s): A total of 182,779 fresh, nondonor, initial ART cycles in women up to age 40 years. Intervention(s): None. Main Outcome Measure(s): Prevalence of DOR and elevated FSH, odds ratio of DOR and elevated FSH in ART mandated vs. nonmandated states, live birth rates. Result(s): Compared with cycles performed in states with mandated ART coverage, cycles in states with no ART mandate were more likely to have DOR (adjusted odds ratio 1.43, 95{\%} confidence interval 1.37-1.5) or elevated FSH (adjusted odds ratio 1.69, 95{\%} confidence interval 1.56-1.85) as the sole reason for treatment. Lack of mandated ART coverage was associated with increased live birth rates in cycles diagnosed as DOR, but not in cycles characterized only by an elevated FSH. Conclusion(s): A significant association was observed between lack of mandated insurance for ART and the proportion of cycles treating DOR or elevated FSH. The presence or absence of state-mandated ART coverage could impact access to care and the mix of patients that pursue and initiate ART cycles in ways that influence these proportions. Additional studies are needed that consider the coalescence of insurance mandates, patient and provider factors, and state-level variables on the odds of specific infertility diagnoses and treatment prognosis.",
keywords = "assisted reproductive technologies (ART), Diminished ovarian reserve, elevated FSH, infertility insurance mandates, SART-CORS database",
author = "Butts, {Samantha F.} and Sarah Ratcliffe and Anuja Dokras and David Seifer",
year = "2013",
month = "2",
doi = "10.1016/j.fertnstert.2012.09.026",
language = "English (US)",
volume = "99",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years

T2 - The role of insurance mandates

AU - Butts, Samantha F.

AU - Ratcliffe, Sarah

AU - Dokras, Anuja

AU - Seifer, David

PY - 2013/2

Y1 - 2013/2

N2 - Objective: To explore correlates of diminished ovarian reserve (DOR) and predictors of assisted reproductive technologies (ART) treatment outcome in DOR cycles using the Society for Assisted Reproductive Technologies-Clinical Outcomes Reporting System (SART-CORS) database; we hypothesized that mandated state insurance coverage for ART is associated with the prevalence of DOR diagnosis in ART cycles and with treatment outcomes in DOR cycles. Design: Cross-sectional study using ART cycles between 2004 and 2007. Setting: Not applicable. Patient(s): A total of 182,779 fresh, nondonor, initial ART cycles in women up to age 40 years. Intervention(s): None. Main Outcome Measure(s): Prevalence of DOR and elevated FSH, odds ratio of DOR and elevated FSH in ART mandated vs. nonmandated states, live birth rates. Result(s): Compared with cycles performed in states with mandated ART coverage, cycles in states with no ART mandate were more likely to have DOR (adjusted odds ratio 1.43, 95% confidence interval 1.37-1.5) or elevated FSH (adjusted odds ratio 1.69, 95% confidence interval 1.56-1.85) as the sole reason for treatment. Lack of mandated ART coverage was associated with increased live birth rates in cycles diagnosed as DOR, but not in cycles characterized only by an elevated FSH. Conclusion(s): A significant association was observed between lack of mandated insurance for ART and the proportion of cycles treating DOR or elevated FSH. The presence or absence of state-mandated ART coverage could impact access to care and the mix of patients that pursue and initiate ART cycles in ways that influence these proportions. Additional studies are needed that consider the coalescence of insurance mandates, patient and provider factors, and state-level variables on the odds of specific infertility diagnoses and treatment prognosis.

AB - Objective: To explore correlates of diminished ovarian reserve (DOR) and predictors of assisted reproductive technologies (ART) treatment outcome in DOR cycles using the Society for Assisted Reproductive Technologies-Clinical Outcomes Reporting System (SART-CORS) database; we hypothesized that mandated state insurance coverage for ART is associated with the prevalence of DOR diagnosis in ART cycles and with treatment outcomes in DOR cycles. Design: Cross-sectional study using ART cycles between 2004 and 2007. Setting: Not applicable. Patient(s): A total of 182,779 fresh, nondonor, initial ART cycles in women up to age 40 years. Intervention(s): None. Main Outcome Measure(s): Prevalence of DOR and elevated FSH, odds ratio of DOR and elevated FSH in ART mandated vs. nonmandated states, live birth rates. Result(s): Compared with cycles performed in states with mandated ART coverage, cycles in states with no ART mandate were more likely to have DOR (adjusted odds ratio 1.43, 95% confidence interval 1.37-1.5) or elevated FSH (adjusted odds ratio 1.69, 95% confidence interval 1.56-1.85) as the sole reason for treatment. Lack of mandated ART coverage was associated with increased live birth rates in cycles diagnosed as DOR, but not in cycles characterized only by an elevated FSH. Conclusion(s): A significant association was observed between lack of mandated insurance for ART and the proportion of cycles treating DOR or elevated FSH. The presence or absence of state-mandated ART coverage could impact access to care and the mix of patients that pursue and initiate ART cycles in ways that influence these proportions. Additional studies are needed that consider the coalescence of insurance mandates, patient and provider factors, and state-level variables on the odds of specific infertility diagnoses and treatment prognosis.

KW - assisted reproductive technologies (ART)

KW - Diminished ovarian reserve

KW - elevated FSH

KW - infertility insurance mandates

KW - SART-CORS database

UR - http://www.scopus.com/inward/record.url?scp=84873294873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873294873&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2012.09.026

DO - 10.1016/j.fertnstert.2012.09.026

M3 - Article

C2 - 23102859

AN - SCOPUS:84873294873

VL - 99

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -